Back to Emerging Issues in Oncology - Updates from ASCO Hem Focus
Emerging Issues in Oncology - Updates from ASCO Hem Focus

Emerging Issues in Oncology - Updates from ASCO Hem Focus

Updates from American Society of Clinical Oncologist (ASCO) – Hematology Focus


Thursday, September 27, 2018
5-6 pm CST

Credits: 1 hour BCOP and/or 1 hour ACPE

BCOP credits are available to earn until March 26, 2019

Product Details

HOPA is pleased to present the fourth of a five-webinar series, which will review key findings from clinical and translational research, and data presented at national oncology meetings.

 

Speaker: Dr. David DeRemer, PharmD BCOP FCCP

 

This session will highlight significant research developments and treatment advances from the ASCO annual meeting. Selected topics will feature innovations in therapies for hematologic malignancies and supportive care interventions for adults and children with cancer.

Upon completion attendee will be able to: 

1. Interpret research findings of key abstracts in hematological malignancies presented at the American Society of Clinical Oncology (ASCO) 54th Annual Meeting

2. Discuss incorporating emerging therapies and novel treatment strategies into clinical practice   

3. Review chimeric antigen receptor therapies (CAR) T-cell therapy data in hematological malignancies presented at the ASCO Annual Meeting

 

  • List Price: $70.00 USD
  • Member Price: $40.00 USD
Join and Save!
Log into see if you qualify for a lower price.
HOPA members save $30.00 USD or more!
Become a member